Quillen, K., Lane, C., Hu, E., Pelton, S. and Bateman, S. (2008) Prevalence of Ceftriaxone-Induced Red Blood Cell Antibodies in Pediatric Patients with Sickle Cell Disease and Human Immunodeficiency Virus Infection. Pediatric Infectious Disease, 27, 357-358.
https://doi.org/10.1097/INF.0b013e3181629a55

has been cited by the following article:

• TITLE: Drug-Induced Hemolytic Anemia: A Fatal Complication Further Under-Recognized in Sickle Cell Disease

  AUTHORS: Monica Khurana, Shekhar S. Raj

  KEYWORDS: Sickle Cell, Hemolytic Anemia, Blood Bank, Pathology

  JOURNAL NAME: Open Journal of Blood Diseases, Vol.7 No.3, September 25, 2017

  ABSTRACT: Drug-induced immune hemolytic anemia (DIIHA) is commonly attributed to cephalosporins. Ceftriaxone is the most frequently administered cephalosporin in patients with sickle cell disease. We present a pediatric patient with severe DIIHA (hemoglobin